CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Acasti Pharma Inc Company Snapshot
Acasti Pharma Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Acasti Pharma Inc with three other companies in this sector in Canada: CO2 GRO Inc (2016 sales of 7,925.00 Canadian Dollars [US$5,958.65 ] ), Novoheart Holdings Inc (10,150.00 Canadian Dollars [US$7,631.58 ] ), and Pacgen Life Science Corporation (65,611.00 Canadian Dollars [US$49,331.60 ] ).

Sales Analysis. Sales fell dramatically in 2016: During the year ended March of 2016, sales at Acasti Pharma Inc were C$37,656.00 (US$28.31 thousand). This is a sharp decrease of 86.1% versus 2015, when the company's sales were C$270,615.00 .
   
   
 
  Stock Performance Chart for Acasti Pharma Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 2.65
(Figures in Canadian Dollars)
1 Week -2.6%   13 Weeks 3.1%  
4 Weeks 6.0%   52 Weeks 170.4%  
 
Acasti Pharma Inc Key Data:
  Ticker: ACST Country: Canada
  Exchanges: VEN Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 37,656
(Year Ending Jan 2017).
Employees: 11
  Currency: Canadian Dollars Market Cap: 225,748,452
  Fiscal Yr Ends: March Shares Outstanding: 85,188,095
  Share Type: Closely Held Shares: 10,377,439
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.